Five important randomized clinical trials in rhinology

PURPOSE OF REVIEW: Randomized clinical trials increasingly guide rhinology as clinicians weigh biologics, topical drug-delivery systems, surgery, and structural interventions. This invited review highlights five randomized clinical trials or trial programs that have meaningfully influenced contemporary rhinology practice. RECENT FINDINGS: The selected trials address common decision points across chronic rhinosinusitis with nasal polyps (CRSwNP), chronic rhinosinusitis without nasal polyps (CRSsNP), and nasal airway obstruction. LIBERTY NP SINUS-24 and SINUS-52 established dupilumab as a benchmark biologic therapy for severe CRSwNP. WAYPOINT supports thymic stromal lymphopoietin inhibition as an effective upstream biologic strategy in severe CRSwNPReOpen1 and ReOpen2 showed that exhalation delivery of fluticasone improves symptoms and radiographic sinus opacification in CRS, including patients without polyps. A pragmatic randomized trial supported endoscopic sinus surgery plus medical therapy as more effective than medical therapy alone in CRSwNP. NAIROS demonstrated superior patient-reported outcomes after septoplasty compared with standardized medical management in adults with nasal obstruction associated with septal deviation. SUMMARY: Together, these trials move rhinology toward more evidence-based, mechanism-informed, and patient-centered treatment selection while highlighting the need for comparative-effectiveness studies and predictive biomarkers.

Authors

Institutions

Publication Details

Journal
Current Opinion in Otolaryngology & Head & Neck Surgery
Published
2026-11-16
DOI
https://doi.org/10.1097/moo.0000000000001166
Primary Topic
Sinusitis and nasal conditions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Five important randomized clinical trials in rhinology

Stacey Tutt Gray, Hoang Bui-Nguyen
3 links
Current Opinion in Otolaryngology & Head & Neck Surgery
Sinusitis and nasal conditions
article

Five important randomized clinical trials in rhinology

Stacey Tutt Gray, Hoang Bui-Nguyen
article en

Abstract

PURPOSE OF REVIEW: Randomized clinical trials increasingly guide rhinology as clinicians weigh biologics, topical drug-delivery systems, surgery, and structural interventions. This invited review highlights five randomized clinical trials or trial programs that have meaningfully influenced contemporary rhinology practice. RECENT FINDINGS: The selected trials address common decision points across chronic rhinosinusitis with nasal polyps (CRSwNP), chronic rhinosinusitis without nasal polyps (CRSsNP), and nasal airway obstruction. LIBERTY NP SINUS-24 and SINUS-52 established dupilumab as a benchmark biologic therapy for severe CRSwNP. WAYPOINT supports thymic stromal lymphopoietin inhibition as an effective upstream biologic strategy in severe CRSwNPReOpen1 and ReOpen2 showed that exhalation delivery of fluticasone improves symptoms and radiographic sinus opacification in CRS, including patients without polyps. A pragmatic randomized trial supported endoscopic sinus surgery plus medical therapy as more effective than medical therapy alone in CRSwNP. NAIROS demonstrated superior patient-reported outcomes after septoplasty compared with standardized medical management in adults with nasal obstruction associated with septal deviation. SUMMARY: Together, these trials move rhinology toward more evidence-based, mechanism-informed, and patient-centered treatment selection while highlighting the need for comparative-effectiveness studies and predictive biomarkers.

Current Opinion in Otolaryngology & Head & Neck Surgery
Massachusetts Eye and Ear Infirmary (US), Harvard University (US)
Good health and well-being
Sinusitis and nasal conditions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon